Serological changes in patients with severe SLE treated with rituximab and cyclophosphamide.

被引：0
|
作者：
Jónsdóttir, Thórunn [1 ]
Gunnarsson, Iva [1 ]
Risselada, Anke [1 ]
Wallerskog, Therese [1 ]
Winqvist, Ola [1 ]
Wikström, Ann-Charlotte [1 ]
Klareskog, Lars [1 ]
van Vollenhoven, Ronald F. [1 ]
机构：
[1] Karolinska Univ Hosp, Stockholm, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S259 / S260
页数：2
相关论文
共 50 条
  • [41] Use of multiplex autoantigen arrays to characterize autoantibody profiles in SLE patients treated with rituximab
    Silverman, GJ
    Looney, RJ
    Warmoth, K
    Burlingame, RW
    Germar, K
    Sanz, I
    Anolik, JH
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S740 - S740
  • [42] Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study
    Bateman, H
    Yazici, Y
    Leff, L
    Peterson, M
    Paget, SA
    LUPUS, 2000, 9 (07) : 542 - 544
  • [43] Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease
    Benad, M.
    Koschel, D.
    Herrmann, K.
    Wiefel, K.
    Kleymann, A.
    Aringer, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (03) : 483 - 488
  • [44] Shrinking Lung Syndrome Successfully Treated with Rituximab and Cyclophosphamide
    Langenskioeld, Elisabeth
    Bonetti, Alessandro
    Fitting, Jean William
    Heinzer, Raphael
    Dudler, Jean
    Spertini, Francois
    Lazor, Romain
    RESPIRATION, 2012, 84 (02) : 144 - 149
  • [45] Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab
    Gelinck, L. B. S.
    Teng, Y. K. O.
    Rimmelzwaan, G. F.
    van den Bemt, B. J. F.
    Kroon, F. P.
    van Laar, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) : 1402 - 1403
  • [46] Poor serological response upon influenza vaccination in patients with rheumatoid arhtritis treated with rituximab
    Gelinck, L.
    Teng, Y.
    Rimmelzwaan, G.
    van den Bemt, B.
    Kroon, F.
    van Laar, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 160 - 160
  • [47] Poor serological response upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab
    Gelinck, L. B. S.
    Teng, Y. K. O.
    Rimmelzwaan, G. F.
    van den Bemt, B. J. F.
    Kroon, F. P.
    van Laar, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A23 - A24
  • [48] Risk Factors for Severe Infections in Patients With Rheumatoid Arthritis Treated With Rituximab in the AutoImmunity and Rituximab Registry
    Gottenberg, J. -E.
    Ravaud, P.
    Bardin, T.
    Cacoub, P.
    Cantagrel, A.
    Combe, B.
    Dougados, M.
    Flipo, R. M.
    Godeau, B.
    Guillevin, L.
    Le Loet, X.
    Hachulla, E.
    Schaeverbeke, T.
    Sibilia, J.
    Baron, G.
    Mariette, X.
    ARTHRITIS AND RHEUMATISM, 2010, 62 (09): : 2625 - 2632
  • [49] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [50] High-dose intravenous cyclophosphamide therapy in severe SLE
    D'Cruz, D
    LUPUS, 2002, 11 (07) : 403 - 404
12345